Access to reliable diagnostics should not depend on privilege. Yet for many patients, high test costs and fragmented systems remain barriers to early detection and ongoing care. AsiaLabs was founded to change that—by combining technology, efficiency, and smart partnerships to make world-class laboratory testing accessible to every clinic, and affordable for every patient.
The Cost Barrier in Diagnostic Healthcare
Laboratory diagnostics are at the foundation of clinical medicine—yet cost remains one of the most persistent barriers for patients.
A liver panel that costs 350,000 VND at a hospital…
Or a basic lipid test that goes for 250,000 VND?
For a patient earning minimum wage—that’s a week’s worth of meals.
Add to that the challenges of travel, inconsistent pricing, and duplicate testing between facilities, and it’s easy to see why millions forgo routine screening each year.
At AsiaLabs, We Makes Quality Lab Testing Affordable to Every Patient
At AsiaLabs, we believe that accurate diagnostics should not depend on income, location, or hospital access. A laboratory test is often the first step toward diagnosis, treatment, and peace of mind—yet too many patients delay testing because of cost. That’s why we’ve built a model where efficiency, not compromise, drives affordability.
Here’s how we’ve made it possible:
-
We centralize testing across multiple clinics – By consolidating equipment and staff, we eliminate redundancy while maintaining consistent standards.
-
We operate with bulk reagent partnerships – Through direct collaborations with leading diagnostic manufacturers, we secure lower reagent costs without reducing quality.
-
We pass these savings to you – Patients and clinics benefit from optimized pricing, with comprehensive panels available from just 80,000–120,000 VND.
Despite this accessibility, our commitment to quality remains absolute. Every test at AsiaLabs is processed under ISO 15189-certified standards, ensuring results are traceable, validated, and reviewed by qualified laboratory scientists. From liver and kidney panels to lipid profiles and hormonal assays, each result undergoes automated cross-checks for accuracy before being released to clinicians.
This is the future of equitable healthcare: precision without exclusion.
Lean Operations, Not Lower Standards
Many assume affordability means compromise—but AsiaLabs challenges that notion.
The key lies in lean laboratory design and process optimization. Every step of the diagnostic chain, from specimen collection to result delivery, is streamlined through automation, digital tracking, and centralized testing.
By investing in:
-
High-throughput analyzers
-
Barcoded specimen logistics
-
Cloud-based LIS (Laboratory Information Systems)
AsiaLabs reduces redundant labor, manual transcription errors, and reagent waste—all while maintaining ISO-accredited quality control. These efficiencies translate directly into cost savings passed on to patients.
Strategic Sourcing and Standardized Panels
Another core strategy is bulk reagent procurement and standardized test panels.
Rather than purchasing small-volume reagents at premium prices, AsiaLabs collaborates with diagnostic manufacturers to negotiate long-term contracts for high-volume usage.
At the same time, its clinical teams have developed evidence-based standard panels—for liver, kidney, thyroid, metabolic, and geriatric profiles—covering 80% of routine diagnostic needs.
By standardizing assays across all partner clinics, AsiaLabs ensures:
-
Consistent results
-
Lower per-test reagent cost
-
Faster turnaround times
This model mirrors the success of large-scale diagnostic networks in Singapore and South Korea, proving that standardization, not price-cutting, drives affordability.
Technology That Eliminates Waste
Digital transformation is another pillar of AsiaLabs’ model.
From automated sample tracking to QR-coded test requisitions, technology minimizes human handling and error—both of which are costly.
For patients, this means:
-
Fewer repeat draws
-
Shorter wait times
-
Instant access to results via patient portals
Internally, digital connectivity allows AsiaLabs to operate on a hub-and-spoke network: smaller clinics collect specimens, while high-complexity tests are processed at central labs.
This reduces unnecessary duplication of analyzers and staff at every branch—a smart cost structure that keeps tests affordable.
Partnerships That Empower Patients
Affordability also depends on ecosystem collaboration. AsiaLabs partners with primary care clinics, corporate health programs, and insurers to integrate testing into existing care pathways.
By sharing infrastructure and electronic systems, each partner avoids redundant overheads, making diagnostic testing part of the normal clinical workflow instead of an expensive add-on.
These partnerships are guided by a “shared access, shared value” philosophy: the more accessible testing becomes, the lower it costs per patient.
The Future: Universal Access Without Universal Cost
AsiaLabs envisions a future where diagnostic testing is as routine as taking blood pressure—a basic right of preventive health.
With innovation in logistics, digitalization, and partnerships, affordability no longer means lower quality—it means higher efficiency.
As regional healthcare systems evolve, AsiaLabs’ model demonstrates how a diagnostic network can be both financially sustainable and socially impactful—bridging the gap between advanced technology and every patient’s budget.
By redefining how laboratories operate—from centralized testing to cost-sharing partnerships—AsiaLabs proves that affordability and accuracy can coexist. Every patient, regardless of income or location, deserves data they can trust and care they can afford. Through innovation and purpose-driven efficiency, AsiaLabs is building the foundation for a more inclusive future in diagnostics—where quality healthcare truly belongs to everyone. Because no patient should ever have to choose between a test and a meal.